About Daiichi Sankyo Europe GmbH
Passion for Innovation. Compassion for Patients.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Munich
- Founded
- 1899
- Company type
- Self-Owned
Daiichi Sankyo is a global healthcare company committed to becoming a trusted healthcare innovator, transforming the lives of people through its strength in science and technology. The company discovers and develops new standards of care to address diverse medical needs to fulfill its purpose of contributing to the enrichment of quality of life around the world.
With a strategic focus on oncology, Daiichi Sankyo is advancing an industry-leading antibody drug conjugate portfolio along with identifying new breakthrough generating technologies to deliver practice-changing medicines to patients, healthcare professionals and society.
Daiichi Sankyo Europe GmbH operates in 15 European countries and in Canada.
If you would like to be an active member of our company in Europe and Canada, we highly appreciate your application. Please take a look at our current vacancies here: https://careers.daiichisankyo.com
Specialties
- cardiovascular diseases
- glucose metabolic disorders
- infectious diseases
- cancer / oncology
- immunity and allergies
- and bones/joint diseases
- antibody drug conjugates
- anticoagulation
- and ADC
Company locations
Zielstattstraße 48, Munich, 81379, DE
Zielstattstrasse 48, Munich, BY 81379, DE
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
On LinkedIn
- Followers
- 69,510
- People linked to this company
- 1,453
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.